Suppr超能文献

慢性肾脏病、终末期肾病以及透析第一年的发病率和死亡率状况。

The state of chronic kidney disease, ESRD, and morbidity and mortality in the first year of dialysis.

机构信息

U.S. Renal Data System, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S-406, Minneapolis, MN 55404, USA.

出版信息

Clin J Am Soc Nephrol. 2009 Dec;4 Suppl 1:S5-11. doi: 10.2215/CJN.05980809.

Abstract

This review examines trends in the ESRD program, assessing progress in preventive care, hospitalizations, and mortality since 1989, the year of the Dallas Morbidity and Mortality Conference. The number of prevalent dialysis patients nearly tripled, to 366,000 in 2007 from 123,000 in 1989. Prevalent population mortality rates declined in the mid-1980s but did not change overall through the 1990s; rates declined for patients on dialysis for less than 5 yr but increased for patients on dialysis for longer than 5 yr. Death rates throughout the prevalent population have subsequently declined since 2000. In the incident dialysis population, death rates after the first year have declined, but first-year rates have remained flat since 1996; rates peak in months 2 and 3, then decline to the level of the first month by 12 mo. Infectious hospitalization rates in the prevalent population increased 40% in the last 10 yr. For incident patients, infectious hospitalizations increased almost 100% over 10 yr, vascular access hospitalizations by 200%, and cardiovascular hospitalizations by 30%. Use of dialysis catheters is high; 82% of patients start dialysis with a catheter. Poor planning for dialysis initiation may contribute to catheter use and the associated high infectious hospitalization rate, limiting potential for improved patient survival during the first year. Public health programs, including the new Medicare chronic kidney disease education benefit, are needed to promote better care of patients who may need dialysis to reduce the high morbidity and mortality in the first year.

摘要

这篇综述考察了终末期肾病(ESRD)项目的发展趋势,评估了自 1989 年达拉斯发病率和死亡率会议以来,在预防保健、住院和死亡率方面取得的进展。1989 年,接受透析治疗的患者人数为 123000 人,而到 2007 年,这一数字几乎翻了三倍,达到 366000 人。1980 年代中期,流行人群的死亡率有所下降,但整个 1990 年代没有变化;透析时间不足 5 年的患者死亡率下降,但透析时间超过 5 年的患者死亡率上升。自 2000 年以来,整个流行人群的死亡率随后有所下降。在新开始透析的患者人群中,第一年的死亡率下降,但自 1996 年以来,第一年的死亡率保持不变;死亡率在第 2 个月和第 3 个月达到峰值,然后在 12 个月内降至第一个月的水平。流行人群中感染性住院率在过去 10 年中增加了 40%。对于新开始透析的患者,10 年内感染性住院率增加了近 100%,血管通路住院率增加了 200%,心血管住院率增加了 30%。透析导管的使用率很高;82%的患者开始透析时使用导管。透析启动规划不佳可能导致导管的使用和相关的高感染性住院率,限制了患者在第一年提高生存率的潜力。需要开展公共卫生项目,包括新的医疗保险慢性肾脏病教育福利,以改善可能需要透析的患者的护理,降低第一年的高发病率和死亡率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验